JT001 (VV116) for the Treatment of COVID-19

Clinical trial NCT05582629 · COMPLETED

Trial details

NCT number: NCT05582629
Sponsor: Shanghai Vinnerna Biosciences Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mild to Moderate COVID-19

Start date: 2022-10-21
Primary completion: 2023-02-14
Enrollment: 1369

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.